Patents Assigned to The Massachusetts General Hospital
-
Patent number: 7169186Abstract: The present invention provides monopolar acetabular liners that can enclose a femoral head to form a hip replacement prosthesis, wherein the liner has a rim that creates an orifice, wherein the orifice has a diameter that is smaller than the diameter of the femoral head, and wherein the liner encompasses greater than 50 percent of the volume of the head, wherein a constraining ring can be used in conjunction with the monopolar constrained acetabular liner to provide additional support for the femoral head to stay with the acetabular liner and avoid dislocation. Assemblies, complete prosthetic replacements, and methods of replacing also are provided. Liners and constraining rings having no, one or more recesses also are provided.Type: GrantFiled: May 15, 2002Date of Patent: January 30, 2007Assignee: Massachusetts General HospitalInventors: William H. Harris, Brian R. Burroughs, Daniel P. Hoeffel
-
Patent number: 7166650Abstract: The present invention provides an irradiated crosslinked polyethylene containing reduced free radicals, preferably containing substantially no residual free radical. Disclosed is a process of making irradiated crosslinked polyethylene by irradiating the polyethylene in contact with a sensitizing environment at an elevated temperature that is below the melting point, in order to reduce the concentration of residual free radicals to an undetectable level. A process of making irradiated crosslinked polyethylene composition having reduced free radical content, preferably containing substantially no residual free radicals, by mechanically deforming the polyethylene at a temperature that is below the melting point of the polyethylene, optionally in a sensitizing environment, is also disclosed herein.Type: GrantFiled: January 7, 2005Date of Patent: January 23, 2007Assignees: Massachusetts General Hospital, Cambridge Polymer Group, Inc.Inventors: Orhun K. Muratoglu, Stephen H. Spiegelberg, Gareth H. McKinley
-
Publication number: 20070004818Abstract: The present invention provides an irradiated crosslinked polyethylene containing reduced free radicals, preferably containing substantially no residual free radical. Disclosed is a process of making irradiated crosslinked polyethylene by irradiating the polyethylene in contact with a sensitizing environment at an elevated temperature that is below the melting point, in order to reduce the concentration of residual free radicals to an undetectable level. A process of making irradiated crosslinked polyethylene composition having reduced free radical content, preferably containing substantially no residual free radicals, by mechanically deforming the polyethylene at a temperature that is below the melting point of the polyethylene, optionally in a sensitizing environment, is also disclosed herein.Type: ApplicationFiled: August 16, 2006Publication date: January 4, 2007Applicants: Massachusetts General Hospital, Cambridge Polymer Group, Inc.Inventors: Orhun Muratoglu, Stephen Spiegelberg, Gareth McKinley
-
Publication number: 20060287646Abstract: Methods and apparatus for dermatology treatment are provided which involve the use of continuous wave (CW) radiation, preheating of the treatment volume, precooling, cooling during treatment and post-treatment cooling of the epidermis above the treatment volume, various beam focusing techniques to reduce scattering and/or other techniques for reducing the cost and/or increasing the efficacy of optical radiation for use in hair removal and other dermatological treatments. A number of embodiments are included for achieving the various objectives indicated above.Type: ApplicationFiled: May 19, 2006Publication date: December 21, 2006Applicants: PALOMAR MEDICAL TECHNOLOGIES, INC., THE GENERAL HOSPITAL CORPORATION D/B/A MASSACHUSETTS GENERAL HOSPITAL, PALOMAR/MGHInventors: Gregory Altshuler, R. Anderson
-
Publication number: 20060258804Abstract: Hyperbranched dendron (HD) polymers are synthesized using low molecular weight polyethyleneimine (BPEI-L) as a core and used for gene delivery. The obtained polymers display low toxicity and efficient gene delivery at low nitrogen-to-phosphate (N/P) ratios. Using successive attachment of ethyleneimine moieties to a PEI core, the polymer has a lower relative ratio of linear-to-branched structures than in the core PEI. The more extensive branching enables the polymer to condense plasmid DNA into nanostructure complexes with a size of less than or equal to about 100 nm. The complexes are stable and efficient in transfecting cells in the presence of serum. Bioluminescent imaging of in vivo gene expression using a luciferase reporter gene performed in live mice showed gene expression in the liver and in submandibular lymph nodes.Type: ApplicationFiled: May 11, 2006Publication date: November 16, 2006Applicant: THE GENERAL HOSPITAL CORPORATION d/b/a MASSACHUSETTS GENERAL HOSPITALInventors: Pallab Banerjee, Wilfried Reichardt, Ralph Weissleder, Alexei Bogdanov
-
Publication number: 20060161145Abstract: The present invention provides devices and methods for applying radiation to the retina of a patient. In one embodiment, an apparatus includes a radiation source for generating a radiation beam suitable for absorption by retinal pigment epithelial cells. One or more optical components are included to direct the beam onto the retina. A scanner is optically coupled to the radiation source to control movement of the beam in two dimensions to allow a scan over the retina. A controller applies control signals to the scanner to adjust beam movement to illuminate a plurality of retinal locations in a temporal sequence according to a predefined pattern. The device can be operated in one mode to effect selective targeting of retinal pigment epithelial cells, or in another mode to effect thermal photocoagulation of the retina.Type: ApplicationFiled: October 31, 2005Publication date: July 20, 2006Applicant: MASSACHUSETTS GENERAL HOSPITALInventors: Charles Lin, Clemens Alt
-
Publication number: 20060140859Abstract: The present invention relates in part to a method of imaging cardiovascular plaque formation in a mammal comprising administering to the mammal an effective amount of 18F-2-fluorodeoxy-D-glucose and then detecting the 18F-2-fluorodeoxy-D-glucose.Type: ApplicationFiled: November 23, 2005Publication date: June 29, 2006Applicant: Massachusetts General HospitalInventors: David Elmaleh, Alan Fischman, John Babich
-
Publication number: 20060134003Abstract: The present invention provides methods and systems for performing in-vivo flow cytometry to obtain desired information regarding one or more cell types of interest flowing through a subject's circulatory system. In one embodiment of the invention, a portion of the subject's circulating blood is illuminated with radiation having multiple wavelength components, and the backscattered radiation generated in response to the excitation radiation is detected at a plurality of scattering angles and analyzed to derive the desired information.Type: ApplicationFiled: December 17, 2004Publication date: June 22, 2006Applicant: MASSACHUSETTS GENERAL HOSPITALInventors: Irene Georgakoudi, Charles Lin
-
Publication number: 20060134005Abstract: The present invention provides methods and systems for performing in vivo flow cytometry. In one embodiments, selected circulating cells of interest of a subject are labeled with fluorescent probe molecules. The labeled cells are irradiated in-vivo so as to excite the fluorescent probes, and the radiation emitted by the excited probes is detected, preferably confocally. The detected radiation is then analyzed to derive desired information, such as relative cell count, of the cells of interest. In some embodiments, the circulating cells comprise apoptotic cells whose detection can allow, e.g., non-invasive monitoring of the efficacy of a cancer treatment, such as an anti-tumor or an anti-angiogenic therapy.Type: ApplicationFiled: July 27, 2005Publication date: June 22, 2006Applicant: MASSACHUSETTS GENERAL HOSPITALInventors: Charles Lin, Xunbin Wei, Dorothy Sipkins
-
Publication number: 20060122668Abstract: A method and apparatus are provided for performing a therapeutic treatment on a patient's skin by concentrating applied radiation of at least one selected wavelength at a plurality of selected, three-dimensionally located, treatment portions, which treatment portions are within non-treatment portions. The ratio of treatment portions to the total volume may vary from 0.1% to 90%, but is preferably less than 50%. Various techniques, including wavelength, may be utilized to control the depth to which radiation is concentrated and suitable optical systems may be provided to concentrate applied radiation in parallel or in series for selected combinations of one or more treatment portions.Type: ApplicationFiled: September 21, 2005Publication date: June 8, 2006Applicants: PALOMAR MEDICAL TECHNOLOGIES, INC., THE GENERAL HOSPITAL CORPORATION d/b/a MASSACHUSETTS GENERAL HOSPITALInventors: R. Anderson, Gregory Altshuler, Dieter Manstein, Sergey Biruchinsky, Andrei Erofeev
-
Publication number: 20050260130Abstract: One aspect of the present invention relates to a method of preparing radiofluorinated substituted alkyl, cycloalkyl, aryl, and alkenyl compounds. In a preferred embodiment, potassium fluoride-18 is used. Another aspect of the invention relates to piperazine compounds containing fluorine-18 that are useful as imaging agents. In certain embodiments, the piperazine compounds contain a quaternary amine. Another aspect of the invention relates to arylphosphonium compounds containing fluorine-18 that are useful as imaging agents. In certain embodiments, the phosphonium compound is a tetraaryl phosphonium salt. Another aspect of the present invention relates to a method of obtaining a positron emission image of a mammal, comprising the steps of administering to a mammal a compound of the invention, and acquiring a positron emission spectrum of the mammal.Type: ApplicationFiled: February 24, 2005Publication date: November 24, 2005Applicant: Massachusetts General HospitalInventors: David Elmaleh, Alan Fischman, Timothy Shoup
-
Publication number: 20050260179Abstract: A method for capturing stem cells and/or progenitor cells from circulating body fluids such as blood or lymph in vivo and enabling the cells to colonize a specific, localized site for purposes of tissue regeneration or repair, has been developed. The method consists of selecting a site in need of repair or regeneration. Materials which can be used to provide the growth factors or ligands include polymeric matrices having the growth factor or ligands attached thereto, materials releasing growth factor or ligands (such as hydrogels, polymers, fibrin clots), and cells which release or have bound to their surfaces the growth factors or ligands.Type: ApplicationFiled: November 6, 2002Publication date: November 24, 2005Applicants: The General Hospital Corporation D/B/A Massachusetts General Hospital, Massachusetts Institute of TechnologyInventors: Mark Fishman, Linda Griffith, Paul Huang
-
Publication number: 20050215988Abstract: A method and apparatus are provided for performing a medical procedure on a patient, for example a dermatological procedure, by use of electromagnetic radiation (EMR) having a relatively low peak power, and in particular a peak power low enough so as not to result in a phase change in the heater or chromophore absorbing radiation which would result in a significant reduction in its absorption, and of relatively long duration which is generally greater than, sometimes significantly greater than, the thermal relaxation time of the irradiated target.Type: ApplicationFiled: March 25, 2005Publication date: September 29, 2005Applicants: PALOMAR MEDICAL TECHNOLOGIES, INC., MASSACHUSETTS GENERAL HOSPITALInventors: Gregory Altshuler, Michael Smotrich, Henry Zenzie, Michael Smirnov, R. Anderson, Dieter Manstein, Eliot Battle
-
Publication number: 20050166929Abstract: Methods and devices are provided that are effective to remove an obstruction in a human airway related to snoring and/or OSA. In one embodiment, the device includes a mouthpiece that is adapted to form a sealed cavity within a human mouth, and a hollow elongate member having a first end that is coupled to the mouthpiece and that is in communication with the sealed cavity, and a second end that is adapted to be coupled to a negative pressure generator. In use, a negative pressure generator can be attached to the hollow elongate member to create a negative pressure in a human mouth in response to an obstructed airway, thereby removing the obstruction. In particular, this device is effective to pull a patient's tongue and/or soft tissues of the upper airway up and away from the posterior pharyngeal wall to reopen the airway.Type: ApplicationFiled: December 22, 2004Publication date: August 4, 2005Applicant: MASSACHUSETTS GENERAL HOSPITALInventor: Yandong Jiang
-
Publication number: 20050146070Abstract: The present invention relates to medical implants that comprise crosslinked polymeric material (such as UHMWPE) that is in contact with another piece (such as a metallic mesh or back, a non-metallic mesh or back, a tibial tray, a patella tray, or an acetabular shell), thereby forming an interface. Also disclosed herein are the methods of manufacturing and sterilizing such medical devices and materials used therein.Type: ApplicationFiled: June 10, 2003Publication date: July 7, 2005Applicant: Massachusetts General HospitalInventors: Orhun Muratoglu, William Harris
-
Publication number: 20050136008Abstract: The invention relates generally to biotin-containing compounds that are useful as imaging agents and drug-delivery agents. Another aspect of the invention relates to the aforementioned compounds chelated to a metal atom. In a preferred embodiment, the metal atom is a gadolinium. Another aspect of the invention relates to a compound comprising three biotin moieties and a pharmaceutical agent covalently bound to a heterocyclic core. In certain embodiments, the pharmaceutical agent is an antibiotic, antiviral, or radionuclide. Another aspect of the present invention relates to a method of treating disease involving administering the compounds of the invention to a mammal. Another aspect of the present invention relates to a method of acquiring a magnetic resonance image using the compounds of the invention.Type: ApplicationFiled: October 1, 2004Publication date: June 23, 2005Applicant: Massachusetts General HospitalInventors: David Elmaleh, Timothy Shoup, Alan Fischman
-
Publication number: 20050124718Abstract: The present invention provides an irradiated crosslinked polyethylene containing reduced free radicals, preferably containing substantially no residual free radical. Disclosed is a process of making irradiated crosslinked polyethylene by irradiating the polyethylene in contact with a sensitizing environment at an elevated temperature that is below the melting point, in order to reduce the concentration of residual free radicals to an undetectable level. A process of making irradiated crosslinked polyethylene composition having reduced free radical content, preferably containing substantially no residual free radicals, by mechanically deforming the polyethylene at a temperature that is below the melting point of the polyethylene, optionally in a sensitizing environment, is also disclosed herein.Type: ApplicationFiled: January 7, 2005Publication date: June 9, 2005Applicants: Massachusetts General Hospital, Cambridge Polymer Group, Inc.Inventors: Orhun Muratoglu, Stephen Spiegelberg, Gareth McKinley
-
Patent number: 6875224Abstract: Devices and methods are provided for diagnosing and repairing mitral valve defects such as mitral valve regurgitation. According to an exemplary method, mitral valve function is visualized by transesophageal echocardiography. A catheter is inserted along the venous system of the patient through the atrium into the mitral valve. A suction tip grasps the leaflets of the mitral valve to immobilize and juxtapose the leaflets at a point simulating a stitch, and the mitral valve is again observed to confirm that fastening at that point will repair the prolapse or other defect. The mitral valve leaflets are then via a fastening such as a staple or shape memory rivet. The fastener may be inserted by a stapling assembly in the venous catheter tip, or by a separate stapler that is inserted along an arterial path from the opposite direction and guided along a transcardiac rail to the immobilized point.Type: GrantFiled: October 17, 2001Date of Patent: April 5, 2005Assignees: Massachusetts General Hospital, The Georgia Tech Research CorporationInventor: Randall Y. Grimes
-
Publication number: 20040259854Abstract: Methods for preventing damage to epithelial tissue during PDT induced using a photosensitizing agent or pre-photosensitizing agent are provided. The methods of the present invention utilize spatial confinement to control photoactivation of the photoactive species to protect the epithelial tissue. In one embodiment, epithelial tissue surrounding a targeted treatment site can be protecting by decreasing the oxygen-content in the tissue, thereby preventing the conversion of the photosensitizer into the phototoxic species in the epithelial tissue.Type: ApplicationFiled: April 14, 2004Publication date: December 23, 2004Applicant: MASSACHUSETTS GENERAL HOSPITALInventors: Richard Rox Anderson, Bernhard Ortel, Eliot F. Battle, Edwin K. Joe
-
Publication number: 20040259855Abstract: Methods for preventing damage to the epidermis during PDT induced using a pre-photosensitizing agent are provided. The methods of the present invention utilize spatial confinement to control formation of a photoactive species from a topically-applied pre-photosensitizing agent. In one embodiment, thermal inhibition is used to prevent the metabolism of a pre-photosensitizing agent in epithelial tissue surrounding a treatment site. In another embodiment, a chemical inhibitor can be applied to the epithelial tissue to inhibit the conversion of a pre-photosensitizing agent into a phototoxic species.Type: ApplicationFiled: April 14, 2004Publication date: December 23, 2004Applicant: MASSACHUSETTS GENERAL HOSPITALInventors: Richard Rox Anderson, Bernhard Ortel, Eliot F. Battle, Edwin K. Joe